AWCluster: A Novel Integrative Network-Based Clustering of Multiomics for Subtype Analysis of Cancer Data

Overview

Journal IEEE/ACM Trans Comput Biol Bioinform

Specialty Biology

Date 2020 Nov 23

PMID 33226952

Citations 8

Authors

Maryam Pouryahya

Jung Hun Oh

Pedram Javanmard

James C Mathews

Zehor Belkhatir

Joseph O Deasy

Allen R Tannenbaum

Affiliations

Soon will be listed here.

Abstract

The remarkable growth of multi-platform genomic profiles has led to the challenge of multiomics data integration. In this study, we present a novel network-based multiomics clustering founded on the Wasserstein distance from optimal mass transport. This distance has many important geometric properties making it a suitable choice for application in machine learning and clustering. Our proposed method of aggregating multiomics and Wasserstein distance clustering (aWCluster) is applied to breast carcinoma as well as bladder carcinoma, colorectal adenocarcinoma, renal carcinoma, lung non-small cell adenocarcinoma, and endometrial carcinoma from The Cancer Genome Atlas project. Subtypes were characterized by the concordant effect of mRNA expression, DNA copy number alteration, and DNA methylation of genes and their neighbors in the interaction network. aWCluster successfully clusters all cancer types into classes with significantly different survival rates. Also, a gene ontology enrichment analysis of significant genes in the low survival subgroup of breast cancer leads to the well-known phenomenon of tumor hypoxia and the transcription factor ETS1 whose expression is induced by hypoxia. We believe aWCluster has the potential to discover novel subtypes and biomarkers by accentuating the genes that have concordant multiomics measurements in their interaction network, which are challenging to find without the network inference or with single omics analysis.

Citing Articles

Biological correlates associated with high-risk breast cancer patients identified using a computational method.

Oh J, Pareja F, Elkin R, Xu K, Norton L, Deasy J NPJ Breast Cancer. 2025; 11(1):8.

PMID: 39875417 PMC: 11775240. DOI: 10.1038/s41523-025-00725-y.

Data Science Opportunities To Improve Radiotherapy Planning and Clinical Decision Making.

Deasy J Semin Radiat Oncol. 2024; 34(4):379-394.

PMID: 39271273 PMC: 11698470. DOI: 10.1016/j.semradonc.2024.07.012.

Dynamic network curvature analysis of gene expression reveals novel potential therapeutic targets in sarcoma.

Elkin R, Oh J, Cruz F, Norton L, Deasy J, Kung A Sci Rep. 2024; 14(1):488.

PMID: 38177639 PMC: 10766622. DOI: 10.1038/s41598-023-49930-4.

Cancer Informatics for Cancer Centers: Sharing Ideas on How to Build an Artificial Intelligence-Ready Informatics Ecosystem for Radiation Oncology.

Bitterman D, Gensheimer M, Jaffray D, Pryma D, Jiang S, Morin O JCO Clin Cancer Inform. 2023; 7:e2300136.

PMID: 38055914 PMC: 10703125. DOI: 10.1200/CCI.23.00136.

Wasserstein HOG: Local Directionality Extraction via Optimal Transport.

Zhu J, Veeraraghavan H, Jiang J, Oh J, Norton L, Deasy J IEEE Trans Med Imaging. 2023; 43(3):916-927.

PMID: 37874704 PMC: 11037420. DOI: 10.1109/TMI.2023.3325295.

References

Soleymani Abyaneh H, Gupta N, Alshareef A, Gopal K, Lavasanifar A, Lai R . Hypoxia Induces the Acquisition of Cancer Stem-like Phenotype Via Upregulation and Activation of Signal Transducer and Activator of Transcription-3 (STAT3) in MDA-MB-231, a Triple Negative Breast Cancer Cell Line. Cancer Microenviron. 2018; 11(2-3):141-152. PMC: 6250616. DOI: 10.1007/s12307-018-0218-0. View

Span P, Manders P, Heuvel J, Thomas C, Bosch R, Beex L . Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer. Oncogene. 2002; 21(55):8506-9. DOI: 10.1038/sj.onc.1206040. View

Dachs G, Patterson A, Firth J, Ratcliffe P, Townsend K, Stratford I . Targeting gene expression to hypoxic tumor cells. Nat Med. 1997; 3(5):515-20. DOI: 10.1038/nm0597-515. View

Dittmer J . The biology of the Ets1 proto-oncogene. Mol Cancer. 2003; 2:29. PMC: 194255. DOI: 10.1186/1476-4598-2-29. View

Parker J, Mullins M, Cheang M, Leung S, Voduc D, Vickery T . Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol. 2009; 27(8):1160-7. PMC: 2667820. DOI: 10.1200/JCO.2008.18.1370. View

Vaupel P, Mayer A . Hypoxia and anemia: effects on tumor biology and treatment resistance. Transfus Clin Biol. 2005; 12(1):5-10. DOI: 10.1016/j.tracli.2004.11.005. View

Zhang S, Li Q, Liu J, Zhou X . A novel computational framework for simultaneous integration of multiple types of genomic data to identify microRNA-gene regulatory modules. Bioinformatics. 2011; 27(13):i401-9. PMC: 3117336. DOI: 10.1093/bioinformatics/btr206. View

Sorlie T, Perou C, Tibshirani R, Aas T, Geisler S, Johnsen H . Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001; 98(19):10869-74. PMC: 58566. DOI: 10.1073/pnas.191367098. View

Weinstein J, Collisson E, Mills G, Mills Shaw K, Ozenberger B, Ellrott K . The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013; 45(10):1113-20. PMC: 3919969. DOI: 10.1038/ng.2764. View

10.

Behrens P, Rothe M, Wellmann A, Krischler J, Wernert N . The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer. J Pathol. 2001; 194(1):43-50. DOI: 10.1002/path.844. View

11.

Nguyen T, Tagett R, Diaz D, Draghici S . A novel approach for data integration and disease subtyping. Genome Res. 2017; 27(12):2025-2039. PMC: 5741060. DOI: 10.1101/gr.215129.116. View

12.

Laderoute K, Calaoagan J, Gustafson-Brown C, Knapp A, Li G, Mendonca H . The response of c-jun/AP-1 to chronic hypoxia is hypoxia-inducible factor 1 alpha dependent. Mol Cell Biol. 2002; 22(8):2515-23. PMC: 133718. DOI: 10.1128/MCB.22.8.2515-2523.2002. View

13.

Hockel M, Vaupel P . Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst. 2001; 93(4):266-76. DOI: 10.1093/jnci/93.4.266. View

14.

Jones P, Baylin S . The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002; 3(6):415-28. DOI: 10.1038/nrg816. View

15.

Cummins E, Taylor C . Hypoxia-responsive transcription factors. Pflugers Arch. 2005; 450(6):363-71. DOI: 10.1007/s00424-005-1413-7. View

16.

Hoadley K, Yau C, Wolf D, Cherniack A, Tamborero D, Ng S . Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell. 2014; 158(4):929-944. PMC: 4152462. DOI: 10.1016/j.cell.2014.06.049. View

17.

Louhimo R, Hautaniemi S . CNAmet: an R package for integrating copy number, methylation and expression data. Bioinformatics. 2011; 27(6):887-8. DOI: 10.1093/bioinformatics/btr019. View

18.

Pradip D, Bouzyk M, Dey N, Leyland-Jones B . Dissecting GRB7-mediated signals for proliferation and migration in HER2 overexpressing breast tumor cells: GTP-ase rules. Am J Cancer Res. 2013; 3(2):173-95. PMC: 3623837. View

19.

Sathyanarayanan A, Gupta R, Thompson E, Nyholt D, Bauer D, Nagaraj S . A comparative study of multi-omics integration tools for cancer driver gene identification and tumour subtyping. Brief Bioinform. 2019; 21(6):1920-1936. PMC: 7711266. DOI: 10.1093/bib/bbz121. View

20.

Vaske C, Benz S, Sanborn J, Earl D, Szeto C, Zhu J . Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics. 2010; 26(12):i237-45. PMC: 2881367. DOI: 10.1093/bioinformatics/btq182. View